Oxygenation Circuit Devices Find A Class II Home With FDA
This article was originally published in The Gray Sheet
The agency issued a final order reclassifying and renaming membrane lung devices to acknowledge their role as one component of a larger extracorporeal membrane oxygenation (ECMO) system. The decision follows 2013 and 2014 advisory panel recommendations.
Register for our free email digests: